Solazyme (SZYM) Posts Q4 Loss of 20c/Share, Misses Views

Solazyme (NASDAQ: SZYM) reported Q4 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $15.05 million.

For earnings history and earnings-related data on Solazyme (SZYM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c